Download PDF
Thromb Haemost 2015; 114(04): 864-865
DOI: 10.1160/TH15-02-0146
Letters to the Editor
Schattauer GmbH

Venous thrombotic burden and the risk of subsequent overt cancer

Paolo Prandoni
1   Department of Cardiovascular Sciences University of Padua, Italy
,
Anthonie W. A. Lensing
1   Department of Cardiovascular Sciences University of Padua, Italy
,
Martin H. Prins
3   Department of Clinical Epidemiology, University of Maastricht, the Netherlands
,
Sabina Villalta
2   Department of Medicine, University of Treviso, Italy
,
Susanna Negri
1   Department of Cardiovascular Sciences University of Padua, Italy
,
Andrea Piccioli
1   Department of Cardiovascular Sciences University of Padua, Italy
,
Franco Noventa
1   Department of Cardiovascular Sciences University of Padua, Italy
› Author Affiliations
Further Information

Publication History

Received: 16 February 2015

Accepted after major revision: 08 May 2015

Publication Date:
29 November 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Prandoni P, Falanga A, Piccioli A. Cancer and venous thromboembolism. Lancet Oncol 2005; 6: 401-410.
    CrossrefPubMedGoogle Scholar
  • 2 Monreal M, Lensing AWA, Prins MH. et al. Screening for occult cancer in patients with acute deep vein thrombosis or pulmonary embolism. J Thromb Haemost 2004; 2: 876-881.
    CrossrefPubMedGoogle Scholar
  • 3 Piccioli A, Lensing AWA, Prins MH. et al. Extensive screening for occult malignant disease in idiopathic venous thromboembolism. J Thromb Hae-most 2004; 2: 884-889.
    CrossrefPubMedGoogle Scholar
  • 4 Van Doormaal FF, Terpstra W, Van Der Griend R. et al. Is extensive screening for cancer in idiopathic venous thromboembolism warranted?. J Thromb Haemost 2011; 9: 79-84.
    CrossrefPubMedGoogle Scholar
  • 5 Piccioli A, Bernardi E, Dalla Valle F. et al. The value of CT scanning for the detection of occult cancer in patients with unprovoked VTE. The D’Acquapendente study. Submitted.
    PubMedGoogle Scholar
  • 6 Di Nisio M, Otten HM, Piccioli A. et al. Decision analysis for cancer screening in idiopathic venous thromboembolism. J Thromb Haemost 2005; 3: 2391-2396.
    CrossrefPubMedGoogle Scholar
  • 7 Bura A, Cailleux N, Bienvenu B. et al. Incidence and prognosis of cancer associated with bilateral venous thrombosis: a prospective study of 103 patients. J Thromb Haemost 2004; 2: 441-444.
    CrossrefPubMedGoogle Scholar
  • 8 Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 2005; 293: 715-722.
    CrossrefPubMedGoogle Scholar
  • 9 Trujillo-Santos J, Prandoni P, Rivron-Guillot K. et al. Clinical outcome in patients with venous thromboembolism and hidden cancer: findings from the RIETE Registry. J Thromb Haemost 2008; 6: 251-255.
    CrossrefPubMedGoogle Scholar
  • 10 Prandoni P, Lensing AWA, Prins MH. et al. The impact of residual thrombosis on the long-term outcome of patients with deep venous thrombosis treated with conventional anticoagulation. Semin Thromb Hemost 2015; 41: 133-140.
    Article in Thieme ConnectPubMedGoogle Scholar